Prostate Cancer Test

OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
BOTHELL, WA, and VANCOUVER, June 21 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC).

Natural Prostate Cancer Treatment Options
What is prostate cancer? Before exploring some information of natural prostate cancer treatment options we have to define first what prostate cancer is. Prostate cancer is the growth of malignant cells in the prostate, walnut-size gland located just below the bladder in men, which produces about 30 percent of the fluid portion of semen.prostate cancer, is common: Men have a lifetime chance of between one in 10 and one in 13 of developing the disease. It is the most commonly diagnosed male cancer and the second leading cause of male cancer deaths. Indeed, autopsy studies have shown that 60 to 70 percent of all men who reach the age of 80 have at least some microscopic evidence of prostate cancer. Symptoms do not occur until the cancer has sp...

Dattoli Advanced Prostate Cancer Treatment Brachytherapy "Seed" Implant Featured in Television Broadcast
Advanced Prostate Cancer Treatment called, brachytherapy (seed implant) was demonstrated by Dr. Michael Dattoli, founder and physician-in-chief of the Dattoli Cancer Center & Brachytherapy Research Institute in Sarasota, in a TV broadcast from WBBH-TV NBC-2 from Fort Myers, FL on August 13, 2009. (link: http://www.nbc-2.com/Global/story.asp?S=10926575)


Prostate Cancer Test


Home Site Map This site may be for sale: Make Inquiry



Privacy Policy | Copyright/Trademark Notification